Therapeutic Asset Ratings

8,399 results matching 1 filter

129,767 assets · 8,707 sponsors · 3,128 indications

Methodology v0.2

Asset	Sponsor	Phase	Rating
Epirubicin Liver Metastases	VA Ann Arbor Healthcare System	P1/2	CCC (51)
Everolimus Acute Myeloid Leukemia	OHSU Knight Cancer Institute	P1/2	CCC (51)
fc084csa tablets Advanced Malignant Solid Tumors	FindCure Biosciences (ZhongShan) Co., Ltd.	P1/2	CCC (51)
Glofitamab Non-Hodgkin Lymphoma	National Cancer Institute (NCI)	P1/2	CCC (51)
Iberdomide Non-Hodgkin Lymphoma	Hoffmann-La Roche	P1/2	CCC (51)
ima203 Refractory Malignant Neoplasm	Immatics US, Inc.	P1/2	CCC (51)
IMMUNOGLOBULIN G4, ANTI-(HUMAN PROGRAMMED CELL DEATH PROTEIN 1) (HUMAN MONOCLONAL REGN2810 HEAVY CHAIN), DISULFIDE WITH HUMAN MONOCLONAL REGN2810 .KAPPA.-CHAIN, DIMER Urinary Bladder Carcinoma	OncoNano Medicine, Inc.	P1/2	CCC (51)
Inno-206 Chronic Myelomonocytic Leukemia	Indiana University	P1/2	CCC (51)
Ipilimumab Sarcoma	Second Affiliated Hospital of Guangzhou Medical University	P1/2	CCC (51)
Lbl-007 Melanoma	Nanjing Leads Biolabs Co.,Ltd	P1/2	CCC (51)
Lipitor Epilepsy	Johns Hopkins University	P1/2	CCC (51)
mln9708 Lymphoblastic Lymphoma	Therapeutic Advances in Childhood Leukemia Consortium	P1/2	CCC (51)
Ngfr-Transduced Autologous T Lymphocytes Metastatic Melanoma	M.D. Anderson Cancer Center	P1/2	CCC (51)
Pembrolizumab Solid Tumor Cancer	GV20 Therapeutics	P1/2	CCC (51)
Pomalidomide Non-Hodgkin Lymphoma	National Cancer Institute (NCI)	P1/2	CCC (51)
rc48-adc Metastatic Cancer	BeOne Medicines	P1/2	CCC (51)
TIL Metastatic Malignant Neoplasm	City of Hope Medical Center	P1/2	CCC (51)
Tisagenlecleucel High-grade B-cell Lymphoma	NeoImmuneTech	P1/2	CCC (51)
Tocilizumab Pancreatic Adenocarcinoma	University of Pennsylvania	P1/2	CCC (51)
Tocilizumab Relapsed/Refractory Diffuse Large B-Cell Lymphoma	Jonsson Comprehensive Cancer Center	P1/2	CCC (51)
Tumor Antigen Loaded Autologous Dendritic Cells Melanoma	Sichuan University	P1/2	CCC (51)
Ublituximab Waldenstrom Macroglobulinemia	Yazeed Sawalha	P1/2	CCC (51)
Veliparib Metastatic Malignant Neoplasm	National Cancer Institute (NCI)	P1/2	CCC (51)
Venetoclax Lymphoblastic Lymphoma	Andrew E. Place, MD	P1/2	CCC (51)
Vinorelbine Head And Neck Cancer	UNICANCER	P1/2	CCC (51)

Showing 726 to 750 of 8,399 assets

PreviousPage 30 of 336Next